Hospital
Baylor Regional Medical Center at Grapevine
Baylor Regional Medical Center at Grapevine was paid $218K by Medicaid between Mar 2021 and Oct 2024, across 24 billing codes. Its largest line is 99284, emergency room visit (serious) — 63% of everything it billed.
33Billing provider infoBAYLOR REGIONAL MEDICAL CENTER AT GRAPEVINE
GRAPEVINE, TX 76051
GRAPEVINE, TX 76051
33aNPI1073511762assigned 07/07/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$218K
24GClaims11,997
24DCodes billed24
24AFirst – last monthMar 2021 – Oct 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#77 of 109
Median peer was paid$1.15M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 2,654 | $50K | |
| 2022 | 4,068 | $89K | |
| 2023 | 3,311 | $45K | |
| 2024incomplete | 1,964 | $34K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 63% | 1,503 | 1,380 | $138K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.3% | 535 | 475 | $16K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.2% | 91 | 90 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.6% | 743 | 678 | $10K |
| 80053 | Comprehensive metabolic panel | 4.4% | 1,746 | 1,425 | $10K |
| 71045 | Radiologic examination, chest; single view | 3.2% | 662 | 609 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 1,947 | 1,572 | $6K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 197 | 186 | $6K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.7% | 90 | 79 | $4K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 111 | 106 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 27 | 27 | $1K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 86 | 83 | $1K |
12 more codes
| 81001 | <1% | 643 | $1K | |
| 81025 | <1% | 130 | $666.22 | |
| 84484 | <1% | 359 | $641.01 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 14 | $638.26 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 27 | $497.50 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 12 | $461.95 |
| 83690 | <1% | 198 | $328.63 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,039 | $239.66 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13 | $92.53 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 232 | $50.47 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 55 | $5.66 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 537 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAJAHAN, NAMAN (CEO)